Skip to content
Home/Companies/Biotech/Oxford Biomedica
OB

Oxford Biomedica

Biotech·UK·Active·5yr hold

Oxford Biomedica is a biotech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Oxford Biomedica?

Oxford Biomedica is currently owned by Vitruvian Partners through Vitruvian Investment Partnership IV (2020 vintage), since 2021.

Hand-verified · updated 2026-07-14

Vitruvian Partners
Investor
Vitruvian Partners
Vitruvian Investment Partnership IV · 2020 · Growth

Key facts

HQUK
SectorBiotech
StatusActive

More from Vitruvian Investment Partnership IV

Other portfolio companies in the same fund.

AnyVan
Active
LogisticsUK· 2022
Civitatis
Active
HospitalitySpain· 2022
Fever
Active
ConsumerSpain· 2022
Logically.ai
Active
AI/MLUK· 2022
Medison
Active
PharmaIsrael· 2022
Meriplex
Active
Business ServicesUnited States· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings